Randomization and Assignment
Randomization implements the protocol schema with stratification, keeping treatment assignment structurally inaccessible to unblinded roles and reporting paths.
Custom Software
Clinical Trial Supply Management Software Development
Clinical trial supply software manages randomization, site inventory, depot distribution, temperature excursion handling, and drug accountability across a study. Blinding integrity governs the architecture, and emergency unblinding must be available continuously while remaining controlled and fully audited.
Trial supply systems carry two constraints that shape everything: a supply failure means a patient misses a dose, and a blinding failure can invalidate a study. Taction Software builds clinical trial supply management capability where those are treated as design requirements rather than operational risks to be monitored after launch.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is Clinical Trial Supply Software
Clinical trial supply management software, frequently called IRT or RTSM, handles subject randomization, treatment assignment, site inventory management, resupply triggering, depot and distribution coordination, expiry and relabeling control, temperature excursion workflow, and drug accountability reconciliation. It sits between the protocol and the physical supply chain, and its records support both study integrity and regulatory accountability. Our work sits within our broader pharma and life sciences practice.
Site Inventory and Resupply
Site inventory tracking triggers resupply against thresholds, balancing stockout risk against the waste that over-supply creates at study close.
Depot and Distribution
Depot management coordinates distribution across regions, drawing on our supply chain management work for logistics modeling.
Temperature Excursion Workflow
Temperature excursions route to quality for disposition. The software documents and escalates; qualified personnel decide whether affected supply remains usable.
Expiry and Relabeling Control
Expiry management tracks shelf life by lot and location, with relabeling and expiry extension handled as controlled, documented events.
Emergency Unblinding
Emergency unblinding is available continuously to authorized users, with full audit capture, since a blocked unblinding during a medical emergency is unacceptable.
Core Clinical Trial Supply Services
Our clinical trial supply management services cover IRT development, inventory and forecasting, depot integration, excursion workflow, and validated delivery. Most engagements involve extending or integrating rather than replacing established IRT platforms, since those handle standard randomization well and replacement carries study risk. We assess that honestly. Engagements typically open with a review of protocol complexity, supply chain footprint, and where current systems constrain study execution.
01
IRT and Randomization Development
We build randomization logic implementing protocol schemas exactly, with validation against the statistical plan before any subject is enrolled.
02
Supply Forecasting and Planning
Supply forecasting models enrollment scenarios against inventory, since both stockout and over-manufacture carry substantial cost in different directions.
03
Depot and Vendor Integration
Integration spans depot systems and logistics vendors, drawing on our logistics and supply chain work for distribution coordination.
04
Excursion and Quality Workflow
Excursion workflow routes temperature events to quality with complete data, so disposition decisions are made by qualified personnel with full context.
05
Accountability and Reconciliation
Drug accountability reconciles dispensed, returned, and destroyed units, producing the records monitoring and inspection examine at site closeout.
06
Part 11 Validated Delivery
Trial supply systems require validation. Our 21 CFR Part 11 for AI work covers audit trails and computer system validation.
Benefits of Purpose-Built Trial Supply Software
The benefits concentrate in supply reliability, reduced waste, and clean accountability records. Trial supply is a forecasting problem with asymmetric costs: stockouts affect patients and protocol compliance, while over-supply produces expensive destruction at study close. We publish no figures on stockout reduction, waste, or supply cost, because those depend entirely on protocol design, enrollment patterns, and therapeutic area.
Reduced Stockout Risk
Resupply triggering against real consumption reduces the stockout risk that causes missed doses and protocol deviations at sites.
Lower Supply Waste
Forecasting against enrollment scenarios reduces over-manufacture, which becomes destruction cost at study close rather than recoverable value.
Clean Accountability Records
Reconciliation produces the accountability documentation monitors verify, reducing closeout findings that originate in incomplete site records.
Faster Excursion Resolution
Structured excursion routing with complete data shortens quarantine time, since quality can decide disposition without assembling context manually.
Protected Study Integrity
Blinding controls designed into architecture prevent the accidental unblinding that operational reporting can otherwise cause invisibly.
Trial Data Continuity
Supply data connects with broader study systems, complementing our clinical trials AI work on trial data integration.
Our Clinical Trial Supply Process
We deliver clinical trial supply management projects in gated phases so clinical operations, supply chain, and quality stakeholders approve direction before engineering cost accumulates. Discovery establishes protocol requirements, supply footprint, and validation scope. Randomization logic is validated against the statistical analysis plan before any live use, and emergency unblinding paths are tested explicitly, since these are the two failure modes with consequences that cannot be undone.
Discovery and Protocol Review
Discovery works from the protocol and statistical plan, since randomization implementation must match exactly rather than approximate the intended design.
Blinding Architecture
Blinding is designed into data architecture and role separation, so treatment assignment is structurally unavailable to operational reporting paths.
Randomization Validation
Randomization logic is validated against the statistical analysis plan with documented testing before any subject is randomized in a live study.
Emergency Unblinding Testing
Unblinding paths are tested explicitly including out-of-hours access, since a blocked emergency unblinding is a patient safety failure.
Supply Chain Integration
Integration with depots and vendors is built and tested, handling the interface variability distribution partners present across regions.
Validated Deployment
Deployment follows IQ, OQ, PQ protocols with documented evidence, followed by change control as protocol amendments affect supply logic.
Technology and Compliance
Trial supply systems operate under GCP, 21 CFR Part 11, GMP requirements for product handling, and import and export regulation for multi-region studies. Taction holds ISO 27001 certification. Three requirements shape architecture. Blinding must be structural rather than permission-based. Emergency unblinding must remain available continuously, since blocking it during a medical emergency is a safety failure. And excursion disposition is a quality decision, so software escalates rather than concludes.
21 CFR Part 11 Compliance
Part 11 requires audit trails, electronic signatures, and computer system validation, which shape architecture from initial design decisions.
Blinding Integrity
Blinding is enforced structurally, since a single operational report exposing treatment assignment can compromise study validity irreversibly.
Emergency Access Availability
Emergency unblinding must function continuously with audit capture, because a blocked unblinding during a medical emergency is unacceptable.
Quality Disposition Boundary
Excursion disposition is decided by qualified quality personnel. The software documents, escalates, and quarantines rather than releasing supply itself.
GMP and Handling Requirements
GMP expectations govern product handling and documentation, informing how storage, transport, and accountability records are structured.
Deployment Security
Deployments run in your cloud tenancy or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare and life sciences software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant discipline here is testing the failure paths rather than the happy path. Emergency unblinding and excursion escalation are the functions that matter most and get exercised least, which is exactly why they need explicit testing. Our leadership brings more than 20 years of personal experience in the field.
01
Failure Path Testing
We test emergency unblinding and excursion escalation explicitly, since these rarely-used paths carry the highest consequence when they fail.
02
Blinding by Architecture
Blinding is structural rather than permission-based, because accidental unblinding through an operational report cannot be remediated afterward.
03
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare and life sciences rather than treating them as one vertical among several.
04
Supply Chain Integration
Our logistics and supply chain work covers distribution modeling, which trial supply requires alongside clinical and regulatory understanding.
05
Validated System Delivery
We produce Part 11 validation evidence as a work product, with change control handling the protocol amendments studies inevitably generate.
06
Certified Security Posture
ISO 27001 certification means security controls are documented and auditable, supporting sponsor and CRO vendor qualification efficiently.
Pricing
Clinical trial supply management pricing depends on scope, protocol complexity, supply footprint, and validation depth. Randomization complexity, multi-region distribution, and cell therapy chain of identity requirements are the largest variables. Most engagements extend or integrate existing IRT platforms rather than replacing them, which costs considerably less. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Depot vendor fees, cloud infrastructure, and platform licensing are separate from engineering.
MVP or Single Module
An MVP covering site inventory tracking or excursion workflow typically runs $40,000 to $80,000 with proportionate validation.
Full Platform Build
A full platform with randomization, inventory, depot integration, and accountability typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-region distribution, portfolio supply, and full validation start at $200,000.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and validation scope reviewed with quality assurance.
Cost Drivers to Expect
Randomization complexity, region count, cell therapy requirements, and validation scope are the largest variables, identified during discovery.
Ongoing Support Costs
Post-launch protocol amendments, depot changes, revalidation, and support are quoted separately as a retainer sized to active study count.
Get Started
If you are evaluating clinical trial supply management software for randomization, inventory forecasting, depot coordination, or excursion workflow, the fastest next step is a discovery call with our team. We will review protocol requirements and supply footprint, scope validation with quality assurance, and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Clinical operations and supply leaders evaluating clinical trial supply management software usually ask about blinding protection, emergency access, and whether replacing an existing IRT is justified. The answers below reflect how we scope these projects.
Structurally, through data architecture and role separation designed before development. Treatment assignment is unavailable to operational reporting paths rather than hidden by permissions. Accidental unblinding through a report is the failure mode that cannot be undone, so it is prevented at design rather than detected afterward.
Authorized users access assignment immediately, at any hour, with full audit capture of who unblinded which subject and when. We test this path explicitly including out-of-hours scenarios, because a system that blocks emergency unblinding during a medical crisis has failed at its most important moment.
No. It captures excursion data, quarantines affected supply, and escalates to quality with complete context. Disposition is a quality decision made by qualified personnel. The software makes that decision faster by assembling the information, not by concluding whether supply remains usable.
Usually not mid-study, and often not at all. Established IRT platforms handle standard randomization well, and replacement carries study risk. Most problems clients describe are addressable through extension, integration, or better forecasting layered onto the existing system.
An MVP covering inventory or excursion workflow runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise multi-region deployments start at $200,000. Validation scope and randomization complexity drive cost most.
With different architecture, yes. Patient-specific therapies require chain of identity tracking linking a specific product to a specific patient, which conventional inventory models do not support. That is a distinct build rather than a configuration of standard trial supply logic.